TLRY vs UPC

Tilray Brands, Inc. vs Universe Pharmaceuticals Inc — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — TLRY scores higher on quality with 6.8/10 vs UPC's 1.5/10. TLRY trades at $5.38 while UPC trades at $3.38. Both analyzed daily using SEC EDGAR data across 13 institutional models.

TLRY

Drug Manufacturers - Specialty & Generic
Tilray Brands, Inc.
Quality
6.8
out of 10
Value Trap
45
WARN
Price
$5.38
Last close
Models
10/13
Active
VS

UPC

Drug Manufacturers - Specialty & Generic
Universe Pharmaceuticals Inc
Quality
1.5
out of 10
Value Trap
15
SAFE
Price
$3.38
Last close
Models
4/13
Active
TLRY
Dynamic NAV sees +32.1% upside
Value Trap 45/100 — caution
UPC
Regime Cross-Sectional sees +235.7% upside
Quality 1.5/10 — below average

TLRY vs UPC — Fair Value Comparison

TLRY
$0$3$6$8 Price$5.38 Bayesian …$1.53 (-71.5%) Dynamic N…$7.11 (+32.1%)
UPC
$0$4$7$11 Price$3.38 Bayesian …$0.66 (-80.5%) Regime Cr…$9.06 (+235.7%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType TLRY Fair ValueTLRY Upside UPC Fair ValueUPC Upside
Bayesian DCF Intrinsic $1.53 -71.5% $0.66 -80.5%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $7.11 +32.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $13.09 +143.2% $9.06 +235.7%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%

TLRY vs UPC — Which Stock Is More Undervalued in 2026?

TLRY scores higher with a 6.8/10 quality rating vs UPC's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do TLRY and UPC Valuations Compare?

At $5.38, TLRY trades +71.5% above its Bayesian DCF fair value of $1.53, while UPC at $3.38 trades +80.5% above its estimate of $0.66. UPC shows a wider gap between price and intrinsic value.

Quality of Company: TLRY vs UPC

TLRY earns a Quality of Company score of 6.8/10 compared to UPC's 1.5/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: TLRY vs UPC

TLRY carries a WARN value trap risk (45/100) while UPC shows SAFE risk (15/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.

Both in Drug Manufacturers - Specialty & Generic

Both TLRY and UPC operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare TLRY vs UPC differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

See all Drug Manufacturers - Specialty & Generic stocks →